Pfizer-BioNTech Covid Booster Shines As CDC Discusses Mix-And-Match Plan

Pfizer-BioNTech Covid Booster Shines As CDC Discusses Mix-And-Match Plan

BioNTech stock jumped Thursday after its Pfizer-partnered booster shot proved more than 95% protective against symptomatic Covid.